International Clinical Trial: A Multicenter Silent Validation and Application Value Evaluation Study of the OsteoSC-M3 Osteoporosis Risk Identification Model Based on Multidimensional Serum Markers

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131832) titled 'A Multicenter Silent Validation and Application Value Evaluation Study of the OsteoSC-M3 Osteoporosis Risk Identification Model Based on Multidimensional Serum Markers' on Sept. 7.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Shanghai Sixth People's Hospital

Condition: Osteoporosis

Intervention: Real-World Observational Subgroup:None Primary OP Cross-Sectional Validation Cohort:None Prospective Longitudinal Follow-up Cohort:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: Real-World Observational Subgroup:260;Pr...